Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: Synergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell lines

Fig. 2

Sensitization of the cervical cancer cell lines to ABT-263 by A-1210477. a SiHa and b CaSki cells were treated with increasing concentrations of ABT-263 (0–32 µM) in the presence or absence of 4 µM of A-1210477 for 72 h. Sensitization of the cervical cancer cell lines to A-1210477 by ABT-263. c SiHa and d CaSki cells were treated with increasing concentrations of A-1210477 (0–32 µM) in the presence or absence of 4 µM and 2 µM of ABT-263, respectively for 72 h. Cell proliferation was assessed using the SyBr Green I assay. Points represent ± SEM of four repeats

Back to article page